From: Targeting myomiRs by tocotrienol-rich fraction to promote myoblast differentiation
Groups | Myogenicity (%) |
---|---|
Young control (PD14) | 95.23 ± 2.14 |
Senescent control (PD21) | 92.84 ± 0.80 |
Young TRF-treated | 96.35 ± 1.87 |
Senescent TRF-treated | 94.22 ± 0.42 |